Pituitary

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	117
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	49
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	42
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	35
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	34
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	33
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	32
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	32
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	31
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	28
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	28
Pituitary: hic manebimus optime	26
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	25
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	23
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria	22
Genetic models of Cushing’s disease	22
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	21
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	21
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	21
Pituitary metastases: a case series and scoping review	20
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	20
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	20
Machine learning as a clinical decision support tool for patients with acromegaly	20
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	19

Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	19
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	18
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	17
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	17
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	16
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	16
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	16
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	16
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	15
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	15
Diagnosis of growth hormone deficiency: searching for Consensus along life	15
IGF-1 is positively associated with BMI in patients with acromegaly	15
Cushing’s disease and bone	15
TSH-secreting pituitary adenomas and bone	14
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	14
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	14
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	14
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	13
Acromegaly is associated with a distinct oral and gut microbiota	13
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	13
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	13
Development and validation of clinical screening systems for Cushing disease in the United States	12
Pituitary surgery and COVID	12
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	12
Is diabetes with acromegaly for life?	12
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study	12
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	12
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	12
Copeptin after pituitary surgery: is it worth measuring?	11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort	11
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	11
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly	10
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Refractory nonfunctioning pituitary adenomas	10
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	10
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly	10
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	10

Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study	10
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	9
Correction: consensus on criteria for acromegaly diagnosis and remission	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	9
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	9
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	9
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease	9
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	9
Skeletal fragility in pituitary disease: how can we predict fracture risk?	9
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	9
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	9
Giant prolactinomas, a detailed analysis of 196 adult cases	8
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	8
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	8
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis	8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	8
An update on, and genetics of refractory adenomas of childhood	8
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	7
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	7
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	7
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	7
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	7
Cushing’s syndrome: Guidance on thromboprophylaxis at last	7
Postoperative weight gain following endoscopic endonasal surgery for craniopharyngiomas in children and adults: A retrospective cohort study	7
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	7
Cushing’s disease: role of preoperative and primary medical therapy	7
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	7
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	7
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism	6
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
Posterior pituitary tumors: an entity unto itself	6
Exercise ventilatory inefficiency may be a specific feature of patients with acromegaly	6
Pituitary acting drugs: cabergoline and pasireotide	6
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	6
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	6
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	6
Cushing’s syndrome and COVID-19	6
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort	6
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	6
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	6
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	6
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	6
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	5
Novel imaging techniques in refractory pituitary adenomas	5
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	5
Cushing’s disease in children: unique features and update on genetics	5
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	5
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	5
Elevated risk of recurrence and retreatment for silent pituitary adenomas	5
Metastases to the pituitary gland: insights from the German pituitary tumor registry	5
Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas	5
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	5
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications	5
Response to letter to the editor “proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors”	4
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	4
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	4
Changing the name of diabetes insipidus	4
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	4
Precocious puberty, pandemic and beyond	4
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	4
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	4
Cushing’s disease: adrenal steroidogenesis inhibitors	4
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	4
Role of Radiation in the treatment of Cushing Disease	4
Vitamin D in pituitary driven osteopathies	4
Urinary incontinence as a novel and underrecognized clinical manifestation of prolactinoma in women	4

Opioids and pituitary function: expert opinion	4
Clinical characteristics, surgical and endocrinological outcomes of sellar and parasellar masses in pediatric patients: a single-center experience	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Hypopituitarism and COVID-19	4
Sheehan syndrome: a current approach to a dormant disease	4
Morphometric study of the pituitary gland and stalk with emphasis on lifestyle factors	4
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	4
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	4
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	4
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	4
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	4
Letter to the editor: Pituitary hyperplasia causing visual symptoms in a young woman planning pregnancy	4
Kidney function in acromegaly: evidence from a long-term observational study	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	4
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	4
Epigenetic implications in the pathogenesis of corticotroph tumors	3
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society	3
Enhancing diagnostic tools for vasopressin deficiency: insights from a single-center cohort study	3
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	3
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	3
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	3
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	3
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	3
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	3
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	3
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	3
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	3
Predictive factors for post-therapeutic biochemical discordance in acromegaly: a monocentric analysis of 156 cases	3